Berry Anderson to Humans
This is a "connection" page, showing publications Berry Anderson has written about Humans.
Connection Strength
0.110
-
Brain stimulation therapies for mood disorders: the continued necessity of electroconvulsive therapy. J Am Psychiatr Nurses Assoc. 2011 May-Jun; 17(3):214-6.
Score: 0.015
-
Decreasing procedural pain over time of left prefrontal rTMS for depression: initial results from the open-label phase of a multi-site trial (OPT-TMS). Brain Stimul. 2009 Apr; 2(2):88-92.
Score: 0.013
-
Tolerability and safety of high daily doses of repetitive transcranial magnetic stimulation in healthy young men. J ECT. 2006 Mar; 22(1):49-53.
Score: 0.010
-
Decreased interhemispheric connectivity and increased cortical excitability in unmedicated schizophrenia: A prefrontal interleaved TMS fMRI study. Brain Stimul. 2020 Sep - Oct; 13(5):1467-1475.
Score: 0.007
-
Improving the antidepressant efficacy of transcranial magnetic stimulation: maximizing the number of stimulations and treatment location in treatment-resistant depression. Depress Anxiety. 2011 Nov; 28(11):973-80.
Score: 0.004
-
Ten sessions of adjunctive left prefrontal rTMS significantly reduces fibromyalgia pain: a randomized, controlled pilot study. Pain. 2011 Nov; 152(11):2477-2484.
Score: 0.004
-
Fractional anisotropy changes after several weeks of daily left high-frequency repetitive transcranial magnetic stimulation of the prefrontal cortex to treat major depression. J ECT. 2011 Mar; 27(1):5-10.
Score: 0.004
-
Safety, tolerability, and effectiveness of high doses of adjunctive daily left prefrontal repetitive transcranial magnetic stimulation for treatment-resistant depression in a clinical setting. J ECT. 2011 Mar; 27(1):18-25.
Score: 0.004
-
Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. Arch Gen Psychiatry. 2010 May; 67(5):507-16.
Score: 0.003
-
Interleaved transcranial magnetic stimulation and fMRI suggests that lamotrigine and valproic acid have different effects on corticolimbic activity. Psychopharmacology (Berl). 2010 Apr; 209(3):233-44.
Score: 0.003
-
Bilateral epidural prefrontal cortical stimulation for treatment-resistant depression. Biol Psychiatry. 2010 Jan 15; 67(2):101-9.
Score: 0.003
-
Focal electrically administered therapy: device parameter effects on stimulus perception in humans. J ECT. 2009 Jun; 25(2):91-8.
Score: 0.003
-
Lamotrigine and valproic acid have different effects on motorcortical neuronal excitability. J Neural Transm (Vienna). 2009 Apr; 116(4):423-9.
Score: 0.003
-
A pilot study of vagus nerve stimulation (VNS) for treatment-resistant anxiety disorders. Brain Stimul. 2008 Apr; 1(2):112-21.
Score: 0.003
-
Focal electrical stimulation as a sham control for repetitive transcranial magnetic stimulation: Does it truly mimic the cutaneous sensation and pain of active prefrontal repetitive transcranial magnetic stimulation? Brain Stimul. 2008 Jan; 1(1):44-51.
Score: 0.003
-
Neurocognitive deficits and prefrontal cortical atrophy in patients with schizophrenia. Schizophr Res. 2008 Apr; 101(1-3):142-51.
Score: 0.003
-
A single 20 mg dose of the full D1 dopamine agonist dihydrexidine (DAR-0100) increases prefrontal perfusion in schizophrenia. Schizophr Res. 2007 Aug; 94(1-3):332-41.
Score: 0.003
-
Brain stimulation for the treatment of psychiatric disorders. Curr Opin Psychiatry. 2007 May; 20(3):250-4; discussion 247-9.
Score: 0.003
-
A single 20 mg dose of dihydrexidine (DAR-0100), a full dopamine D1 agonist, is safe and tolerated in patients with schizophrenia. Schizophr Res. 2007 Jul; 93(1-3):42-50.
Score: 0.003
-
Reducing pain and unpleasantness during repetitive transcranial magnetic stimulation. J ECT. 2006 Dec; 22(4):259-64.
Score: 0.003
-
Acute and long-term VNS effects on pain perception in a case of treatment-resistant depression. Neurocase. 2006 08; 12(4):216-20.
Score: 0.003
-
Vagus nerve stimulation affects pain perception in depressed adults. Pain Res Manag. 2005; 10(1):9-14.
Score: 0.002
-
Acute vagus nerve stimulation using different pulse widths produces varying brain effects. Biol Psychiatry. 2004 Apr 15; 55(8):816-25.
Score: 0.002
-
Safety and benefits of distance-adjusted prefrontal transcranial magnetic stimulation in depressed patients 55-75 years of age: a pilot study. Depress Anxiety. 2004; 19(4):249-56.
Score: 0.002
-
Can left prefrontal rTMS be used as a maintenance treatment for bipolar depression? Depress Anxiety. 2004; 20(2):98-100.
Score: 0.002
-
Left prefrontal transcranial magnetic stimulation (TMS) treatment of depression in bipolar affective disorder: a pilot study of acute safety and efficacy. Bipolar Disord. 2003 Feb; 5(1):40-7.
Score: 0.002